Combined therapy with insulin lispro mix 75/25 plus metformin or insulin glargine plus metformin: A 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy
- 31 December 2004
- journal article
- clinical trial
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 26 (12), 2034-2044
- https://doi.org/10.1016/j.clinthera.2004.12.015
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Glimepiride Combined with Morning Insulin Glargine, Bedtime Neutral Protamine Hagedorn Insulin, or Bedtime Insulin Glargine in Patients with Type 2 DiabetesAnnals of Internal Medicine, 2003
- Standards of Medical Care for Patients With Diabetes MellitusDiabetes Care, 2002
- Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.Diabetes Care, 2000
- Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro Mix25 and insulin lispro Mix50Clinical Therapeutics, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study GroupDiabetes, 1997
- Analysis of the crossover design in the presence of residual effectsStatistics in Medicine, 1991
- The Two Period Binary Response Cross‐Over TrialBiometrical Journal, 1986
- A Note on the Use of Nonparametric Methods in the Statistical Analysis of the Two-Period Changeover DesignPublished by JSTOR ,1982
- 328. Note: The Use of None-Parametric Methods in the Statistical Analysis of the Two-Period Change-Over DesignPublished by JSTOR ,1972